BS.c in Psychology MS.c and Ph.D in Clinical Psychology
Postdoctoral Mixed Methods Research Associate
Vasilis S. Vasiliou is a Clinical Psychologist by training and research (Ph.D.), with a specialization in Health Psychology and Behavioural Medicine. His research emphasizes the application of the newest Contextual Cognitive-Behavioral interventions (e.g., Acceptance and Commitment Therapy, Mindfulness, etc) in chronic illness and chronic pain management.
He has a bachelor’s degree in psychology from the University of Crete, Greece, a master's degree from Swansea University, Wales, UK, and a Ph.D. in Clinical Psychology at the University of Cyprus. He also holds a Post-graduate Certificate (Pg. Cert.) in Teaching and Learning in Higher Education (CKBO2, NFQ Level 9) from the University College Cork (UCC), Ireland.
He employs mixed methods (triangulating quantitative and qualitative data), participatory designs (e.g., interventions developed from public and patient involvement groups- PPI), and multilevel models to understand how digital, personalized, modularized assessment and intervention tools can be implemented in different clinical settings.
He works as a Post-Doctoral Research Associate at Botnar Research Center, Luqmani Group, where he leads a mixed-method study named VAS- UP: UPgrading multilevel methods of assessing toxicity from steroids in VASculitis and other related conditions.
VAS-UP project attempts to examine how clinicians and patients measure and track the toxicity of steroids. We are primarily interested in identifying whether there is a gap between methods of assessing the toxicity of steroids, and how these methods reflect the real clinical needs in daily practice. We will also provide implementation practices, such as parameters (e.g., domains in implementation practice, e.g. beliefs about capabilities, knowledge, skills, social/professional role and identity, environmental context/resources, Memory, attention and decision processes, etc.) that are likely to increase the frequency of methods used, to assess the toxicity from steroids.
The project has three main aims that will be examined in three phases:
 Identify determinants (barriers/facilitators) that are likely to increase the use of methods (e.g., (indices or patient Reported Outcome Measures- PROMs) that help clinicians and patients in the assessment and monitoring of steroid toxicity.
 Assess how patients and clinicians respond to toxicity (e.g., clinicians’ health care behaviors when assessing for toxicity and patients’ responses to toxicity) and how these responses (narrow or effective behavioral repertoires) lead to better or worst care.
 Explore what best methods (or ways) clinicians and patients can use to track and assess the toxicity of steroids and how patients' responses to toxicity lead to better or worst outcomes.